Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tina S Wu

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Pharmacotherapy|January 17, 2002
Sexual dysfunction secondary to gemfibrozilChristopher W James, Tina S Wu, Kelly C McNelis
Journal of the American College of Radiology : JACR|January 3, 2019
The Use of an Emergency Department Expeditor to Improve Emergency Department CT Workflow: Initial ExperiencesSoterios Gyftopoulos, Catherine Jamin, Tina S Wu, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|August 22, 2009
Adding the p16(INK4a) marker to the traditional 3-marker (ER/Vim/CEA) panel engenders no supplemental benefit in distinguishing between primary endocervical and endometrial adenocarcinomas in a tissue microarray studyChih-Ping Han, Ming-Yung Lee, Lai-Fong Kok, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|April 7, 2009
Scoring of p16(INK4a) immunohistochemistry based on independent nuclear staining alone can sufficiently distinguish between endocervical and endometrial adenocarcinomas in a tissue microarray studyChih-Ping Han, Lai-Fong Kok, Po-Hui Wang, et al.
Archives of Gynecology and Obstetrics|October 23, 2009
A reappraisal of three-marker (ER/Vim/CEA), four-marker (ER/Vim/CEA/PR), and five-marker (ER/Vim/CEA/PR/p16INK4a) panels in the diagnostic distinction between primary endocervical and endometrial adenocarcinomas in a tissue microarray studyChih-Ping Han, Ming-Yung Lee, Lai-Fong Kok, et al.
Archives of Gynecology and Obstetrics|May 7, 2009
Comparing the scoring mechanisms of p16INK4a immunohistochemistry based on independent nucleic stains and independent cytoplasmic stains in distinguishing between endocervical and endometrial adenocarcinomas in a tissue microarray studyLai-Fong Kok, Ming-Yung Lee, Yeu-Sheng Tyan, et al.
Archives of Gynecology and Obstetrics|May 16, 2009
Five commonly used markers (p53, TTF1, CK7, CK20, and CK34betaE12) are of no use in distinguishing between primary endocervical and endometrial adenocarcinomas in a tissue microarray extension studyChih-Ping Han, Lai-Fong Kok, Ming-Yung Lee, et al.
Journal of Translational Medicine|April 16, 2009
Scoring mechanisms of p16INK4a immunohistochemistry based on either independent nucleic stain or mixed cytoplasmic with nucleic expression can significantly signal to distinguish between endocervical and endometrial adenocarcinomas in a tissue microarray studyChiew-Loon Koo, Lai-Fong Kok, Ming-Yung Lee, et al.
Archives of Gynecology and Obstetrics|January 21, 2009
Ancillary p16(INK4a) adds no meaningful value to the performance of ER/PR/Vim/CEA panel in distinguishing between primary endocervical and endometrial adenocarcinomas in a tissue microarray studyChung-Chin Yao, Lai-Fong Kok, Ming-Yung Lee, et al.
Journal of Translational Medicine|May 30, 2009
Progesterone receptor does not improve the performance and test effectiveness of the conventional 3-marker panel, consisting of estrogen receptor, vimentin and carcinoembryonic antigen in distinguishing between primary endocervical and endometrial adenocarcinomas in a tissue microarray extension studyChiung-Ling Liao, Ming-Yung Lee, Yeu-Sheng Tyan, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Pharmacotherapy|January 17, 2002
Sexual dysfunction secondary to gemfibrozilChristopher W James, Tina S Wu, Kelly C McNelis
Journal of the American College of Radiology : JACR|January 3, 2019
The Use of an Emergency Department Expeditor to Improve Emergency Department CT Workflow: Initial ExperiencesSoterios Gyftopoulos, Catherine Jamin, Tina S Wu, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|August 22, 2009
Adding the p16(INK4a) marker to the traditional 3-marker (ER/Vim/CEA) panel engenders no supplemental benefit in distinguishing between primary endocervical and endometrial adenocarcinomas in a tissue microarray studyChih-Ping Han, Ming-Yung Lee, Lai-Fong Kok, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|April 7, 2009
Scoring of p16(INK4a) immunohistochemistry based on independent nuclear staining alone can sufficiently distinguish between endocervical and endometrial adenocarcinomas in a tissue microarray studyChih-Ping Han, Lai-Fong Kok, Po-Hui Wang, et al.
Archives of Gynecology and Obstetrics|October 23, 2009
A reappraisal of three-marker (ER/Vim/CEA), four-marker (ER/Vim/CEA/PR), and five-marker (ER/Vim/CEA/PR/p16INK4a) panels in the diagnostic distinction between primary endocervical and endometrial adenocarcinomas in a tissue microarray studyChih-Ping Han, Ming-Yung Lee, Lai-Fong Kok, et al.
Archives of Gynecology and Obstetrics|May 7, 2009
Comparing the scoring mechanisms of p16INK4a immunohistochemistry based on independent nucleic stains and independent cytoplasmic stains in distinguishing between endocervical and endometrial adenocarcinomas in a tissue microarray studyLai-Fong Kok, Ming-Yung Lee, Yeu-Sheng Tyan, et al.
Archives of Gynecology and Obstetrics|May 16, 2009
Five commonly used markers (p53, TTF1, CK7, CK20, and CK34betaE12) are of no use in distinguishing between primary endocervical and endometrial adenocarcinomas in a tissue microarray extension studyChih-Ping Han, Lai-Fong Kok, Ming-Yung Lee, et al.
Journal of Translational Medicine|April 16, 2009
Scoring mechanisms of p16INK4a immunohistochemistry based on either independent nucleic stain or mixed cytoplasmic with nucleic expression can significantly signal to distinguish between endocervical and endometrial adenocarcinomas in a tissue microarray studyChiew-Loon Koo, Lai-Fong Kok, Ming-Yung Lee, et al.
Archives of Gynecology and Obstetrics|January 21, 2009
Ancillary p16(INK4a) adds no meaningful value to the performance of ER/PR/Vim/CEA panel in distinguishing between primary endocervical and endometrial adenocarcinomas in a tissue microarray studyChung-Chin Yao, Lai-Fong Kok, Ming-Yung Lee, et al.
Journal of Translational Medicine|May 30, 2009
Progesterone receptor does not improve the performance and test effectiveness of the conventional 3-marker panel, consisting of estrogen receptor, vimentin and carcinoembryonic antigen in distinguishing between primary endocervical and endometrial adenocarcinomas in a tissue microarray extension studyChiung-Ling Liao, Ming-Yung Lee, Yeu-Sheng Tyan, et al.
Pageof 1